BioArctic presented a symposium together with its partner Eisai at the 10th International Conference on Alzheimer´s & Parkinson´s Diseases (AD/PD) in Barcelona March 9 – 13th.
During this conference several presentations highlighted the central role of Abeta protofibrils in the pathogenesis of Alzheimer´s disease. The session was the most attended during the conference with 1600 attendees. The importance of protofibrils as drug target was presented together with an update on current immunotherapy trials in Alzheimer´s disease. Also clinical studies with BAN2401, an Abeta protofibril specific monoclonal antibody, were described. How to use biomarkers for the diagnosis and assessment of clinical efficacy was also highlighted during the BioArctic/Eisai symposium. Please download the pdf for details of the symposium.